New drug combo aims to tame Tough-to-Treat blood cancer
Disease control
Not yet recruiting
This study is testing if adding an experimental drug called HMPL-760 to a standard chemotherapy regimen (R-GemOx) works better than the chemotherapy alone for patients with an aggressive type of lymphoma that has returned or not responded to prior treatment. About 240 adults with…
Phase: PHASE3 • Sponsor: Hutchmed • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC